Patient Outcomes After Hepatic Artery Infusion Pump Placement

Patient Reported Outcomes After Hepatic Artery Infusion Pump Placement

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05468593

Enrollment

Registered

2022-07-21

Start date

2022-07-12

Completion date

2024-07-01

Last updated

2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colorectal Liver Metastases

Keywords

Hepatic Artery Infusion, Pump, Hepatic Artery Infusion Chemotherapy, Unresectable Colorectal Liver Metastases

Brief summary

The purpose of this study is to evaluate the surgical outcomes and the quality of life (QOL) in patients undergoing hepatic artery infusion pump placement for colorectal liver metastases (CRLM).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Patients who receive a Hepatic Artery Infusion Pump at Mayo Clinic Rochester for liver metastases from colorectal cancer. * Written consent.

Exclusion criteria

* Absence of written consent. * Systemic disease. * Pregnancy.

Design outcomes

Primary

Measure	Time frame	Description
Quality of Life	Baseline prior to surgery.	Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time.

Secondary

Measure	Time frame	Description
Time to start chemotherapy	1 month postoperatively	Number of days following hepatic artery infusion pump placement until chemotherapy is started
Surgical outcomes	1 month postoperatively	Complications with hepatic artery infusion pump placement

Countries

United States

Outcome results